- Research works
- 29 ▼ 59% vs 2013–17
- Citations
- 718 24.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Boehringer Ingelheim (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Psychology, 3.0×. Every wedge is a field page.
Which keywords describe research at Boehringer Ingelheim (Denmark)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Vaccine, Glycemic Control, Insulin Therapy, Urinary Incontinence, Inflammation and Global Burden.
- spirometry
- Liquidity
- COPD
- Regulation
- Finance
- Climate Change
- Risk Factors
- Management
- Chemotherapy
- Quality of Life
- Coronavirus
- Heart Failure
- Diagnosis
- Global Burden
- Insulin Therapy
- Inflammation
- Pathogenesis
- Epidemiology
- Vaccine
- Glycemic Control
- Cardiovascular Disease
- Urinary Incontinence
- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms
- Porcine Reproductive and Respiratory Syndrome Virus
- Targeted Therapy
- Clinical Guidelines
- Norovirus
- Rotavirus
- Clinical Trials
- Oxidative Stress
- Banking
- Diabetes Mellitus
- Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Epidemiology5▲ 4.4×16 topics
- Pathogenesis2▲ 15×2 topics
- Vaccine2▲ 21×2 topics
- Inflammation2▲ 3.6×11 topics
- Glycemic Control2▲ 49×4 topics
- Insulin Therapy2▲ 59×3 topics
- Cardiovascular Disease2▲ 5.4×8 topics
- Global Burden2▲ 11×6 topics
- Urinary Incontinence2▲ 66×2 topics
- Diagnosis2▲ 5.5×5 topics
- Benign Prostatic Hyperplasia2▲ 129×1 topic
- Heart Failure2▲ 11×3 topics
- Lower Urinary Tract Symptoms2▲ 129×1 topic
- Coronavirus1▲ 39×1 topic
- Porcine Reproductive and Respiratory Syndrome Virus1▲ 125×1 topic
- Quality of Life1▲ 3.5×10 topics
- Targeted Therapy1▲ 20×4 topics
- Chemotherapy1▲ 5.7×10 topics
- Clinical Guidelines1▲ 14×2 topics
- Management1▲ 5.5×4 topics
- Norovirus1▲ 70×1 topic
- Risk Factors1▲ 3.9×6 topics
- Rotavirus1▲ 70×1 topic
- Climate Change1▲ 1.50×4 topics
- Clinical Trials1▲ 6.3×2 topics
- Finance1▲ 30×2 topics
- Oxidative Stress1▲ 1.98×5 topics
- Regulation1▲ 6.2×2 topics
- Banking1▲ 75×1 topic
- COPD1▲ 56×1 topic
- Diabetes Mellitus1▲ 15×3 topics
- Liquidity1▲ 32×1 topic
- Treatment1▲ 2.7×5 topics
- spirometry1▲ 56×1 topic
Which research topics does Boehringer Ingelheim (Denmark) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Health Policy Implementation Science and Animal Virus Infections Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 3 Health Policy Implementation Science General Health Professions 0 works
- 4 Animal Virus Infections Studies Animal Science and Zoology 0 works
- 5 Virus-based gene therapy research Genetics 0 works
- 6 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 7 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
- 8 Schizophrenia research and treatment Psychiatry and Mental health 0 works
- 9 Healthcare Decision-Making and Restraints Clinical Psychology 0 works
- 10 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Denmark)'s research output changed?
Output in 2018–2022 was 59% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Copenhagen
- University of Copenhagen
- Rigshospitalet
- Copenhagen Business School
- Copenhagen University Hospital
- Gentofte Hospital
- Bispebjerg Hospital
- Statens Serum Institut
- Novo Nordisk (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.